ZYXEL
27.2.2024 16:55:34 CET | Business Wire | Press release
Türk Telekom, pioneer of digital transformation Türkiye, has completed the world’s first mass deployment of Software-Defined Fiber Broadband. By using Netsia’s BB Suite and Zyxel’s Whitebox OLT, Türk Telekom has taken an important step towards fulfilling its virtualized and disaggregated broadband network strategy and thus, providing world-class, modern, high quality and high-speed broadband services.
“Beyond our role as a telecommunications operator, we are leading Türkiye's ambition to become a significant player in technology exports through our pioneering initiatives and partnerships. While supporting our local ecosystem through collaborations within our country, we are also elevating the prestige and value of our nation through our global endeavors," says Ümit Önal, CEO at Türk Telekom. “The cutting-edge fiber infrastructure technology product Zyxel, developed by Argela, our company renowned for innovative solutions, along with its US subsidiary Netsia, has evolved into an innovation that sets global standards. We are delighted to contribute to our country's vision of becoming a technology-exporting nation through the contract we have signed with Zyxel.”
Zyxel and Netsia have successfully completed the integration of Zyxel’s SDA Series Combo Whitebox OLT with Netsia’s BB Suite to realize the fully disaggregated broadband access network. The integrated solution has been tested in Türk Telekom’s live network and is now ready for deployment by all service providers globally. The partnership was made official with a contract signing ceremony held at this year’s Mobile World Congress on February 27. In attendance for the signing ceremony was Republic of Türkiye Deputy Transport and Infrastructure Minister Ömer Fatih Sayan.
The Netsia BB Suite provides network operators with an open, multi-vendor platform based on open-source SEBA project and BBF data models. Netsia BB Suite enables network operators to extend software defined programming to the fixed access network with customized support for each operator’s unique services and workflows. By enabling a fully disaggregated network, service providers are no longer committed to one vendor to fulfill all their needs. Instead, they have full flexibility to choose products and partners that work best for them, while having the flexibility to customize the solution to their needs.
Türk Telekom chose Zyxel’s Multi SDA products , which are all-in-one PON Whitebox OLT’s that are fully equipped to provide scalability, flexibility and interoperability to the Netsia BB Suite. The OLT’s have features that simultaneously support XGS-PON, GPON and Combo PON technologies, designed to make it easier for operators to adopt new technologies that integrate seamlessly with this solution.
“Netsia’s BB Suite is one of the most mature versatile solutions in the market, and our SDA Series Combo is designed to jointly further the network disaggregation evolution,” says Karsten Gewecke, President at Zyxel Communications. “We wanted to develop a flexible, future proof solution that creates an open broadband-access environment with vendor-agnostic hardware, keeping service providers ahead of the competition.”
Netsia CEO C. Bora Eliaçık says: “Türk Telekom, a globally recognized leader in telecommunications, is at the forefront of innovation in the Software-defined Fiber Broadband arena. We are honored to partner with them on this transformative journey. Our Netsia BB Suite product is designed to revolutionize how operators manage their access networks by providing a unified, powerful management solution. This collaboration marks a significant milestone in the evolution of access network management.” Eliaçık adds: “Our BB Suite allows the broadband access network to adapt itself to different service requirements and customer experience needs. The solution also supports the operators to optimize the CAPEX and OPEX costs by breaking the vendor lock, allowing more controllable and flexible PON networks and thus enabling critical features and services in the network. Our cooperation with Zyxel is extremely fruitful and we thank them for their collaboration and look forward to continuing our successful partnership.”
About Türk Telekom:
Türk Telekom, with over 180 years of history, is the first integrated telecommunications operator in Türkiye. Having a wide service network and product range in the fields of individual and corporate services, Türk Telekom unified its mobile, internet, phone and TV products and services under the single “Türk Telekom” brand. “Türkiye’s Multiplay Provider” Türk Telekom has 17.4 million fixed access lines, 15.1 million fixed broadband, 26.1 million mobile and 2.9 million TV subscribers as of September 30, 2023. Türk Telekom Group Companies provide services in all 81 cities of Türkiye with nearly 38.000 employees with the vision of introducing new technologies to Türkiye and accelerating Türkiye’s transformation into an information society. www.turktelekom.com.tr
About Netsia:
Netsia, a US subsidiary of Argela, is based in Santa Clara, California in the heart of Silicon Valley. With key architects, engineers and product people, Netsia is developing leading edge solutions for the telecom industry. Netsia is in active participation with open source communities and standards bodies and provides enriched, telco-grade, and supported distributions of the open source platforms. www.netsia.com
About Zyxel Communications
Zyxel Communications delivers technological innovations and has connected the world to the internet for more than 30 years. Whether establishing access through fixed or mobile broadband solutions, Zyxel Communications offers a comprehensive and flexible portfolio of products that’s keeping service providers ahead of the competition. Come by our booth at MWC 2024 to know more about our solutions and partnerships: Homepage | EMEA | Zyxel
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227158748/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
